Gene and immune therapy for renal cell carcinoma

International Journal of Urology

Volumn 8, Issue 7, 2001, Pages

  Pantuck, Allan J ^a   Zisman, Amnon ^a   Belldegrun, Arie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokine; Gene therapy; Immunotherapy; Renal cell carcinoma; Tumor vaccine

Indexed keywords

ALPHA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA 137 ANTIGEN; HLA ANTIGEN; HLA B7 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; PROTEIN; PROTEIN P53; TUMOR ANTIGEN; TUMOR ANTIGEN G250; TUMOR VACCINE; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CARCINOGENESIS; CHROMOSOME ABERRATION; CLINICAL TRIAL; CONFERENCE PAPER; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SAFETY; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENICITY; KIDNEY CARCINOMA; LATENT PERIOD; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

CANCER VACCINES; CARCINOMA, RENAL CELL; GENE THERAPY; HUMANS; IMMUNOTHERAPY; KIDNEY NEOPLASMS;

EID: 0035570365     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2001.00326.x     Document Type: Conference Paper

References (14)

1. Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line
2. Quantitative studies on tissue transplantation immunity. Volume II: The origin, strength and duration of activity and adoptively acquired immunity
3. Immunity to methylcholanthrene-induced sarcomas
4. The concept of immunological surveillance
5. Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors
6. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 in patients with metastatic cancer
7. Interleukin-2: Inception, impact, and implications
8. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): Implications for live cancer vaccines
9. Immunotherapy and gene therapy
10. Screening for von Hippel-Lindau disease by DNA polymorphism analysis
11. Identification of the von Hippel-Lindau disease tumor suppressor gene
12. Experimental p53 gene therapy in renal cell carcinoma
13. Antibody localization in human renal cell carcinoma: A phase I study of monoclonal antibody G250